Instem plc
("Instem" or the "Company")
Notice of AGM
Instem plc (AIM: INS), a leading provider of IT solutions to the global life sciences market, announces that its Annual Report for the year-ended 31 December 2017, together with the Notice of Annual General Meeting (the "AGM") and Form of Proxy for the AGM, was sent to shareholders on 30 April 2018. The Annual Report and Notice are also available to view or download from the Company's website at www.instem.com.
The Company's AGM will be held at the offices of RSM, 3 Hardman Street, M3 3HF on Thursday 24 May 2018 at 10:00 am.
For further information, please contact:
Instem plc |
+44 (0) 1785 825 600 |
Phil Reason, CEO |
|
Nigel Goldsmith, CFO |
|
|
|
N+1 Singer (Nominated Adviser & Broker) |
+44 (0) 20 7496 3000 |
Richard Lindley James White |
|
|
|
Walbrook Financial PR |
+44 (0) 20 7933 8000 |
Paul Cornelius |
|
Helen Cresswell Sam Allen
|
|
|
|
About Instem
Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.
Instem solutions are in use by customers worldwide and enable our clients to bring life enhancing products to market faster.
Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.
Instem supports over 500 clients through offices in the United States, United Kingdom, France, Japan, China and India.
To learn more about Instem solutions and its mission, please visit instem.com.